Skip to main content
. 2012 May 15;185(10):1073–1080. doi: 10.1164/rccm.201111-2075OC

Figure 2.

Figure 2.

Nonmetric multidimensional scaling analysis of the terminal restriction fragment length polymorphism profiles that provided adequate number of amplicons. Three distinct groups can be discerned, with the negative control subjects clustering close to the cystic fibrosis sample group. COPD = chronic obstructive pulmonary disease; GOLD = Global Initiative for COPD.